Dyslipidemia in Patients with a Cardiovascular Risk and Disease at the University Teaching Hospital of Yaoundé, Cameroon
- PMID: 28163932
- PMCID: PMC5253480
- DOI: 10.1155/2017/6061306
Dyslipidemia in Patients with a Cardiovascular Risk and Disease at the University Teaching Hospital of Yaoundé, Cameroon
Abstract
Objective. To determine the frequency of lipid abnormalities in patients with a cardiovascular risk and disease at the University Teaching Hospital (UTH) of Yaoundé. Materials and Methods. We conducted a cross-sectional study from 1 March to 31 May 2015 at the UTH of Yaoundé. We included all patients seen in the outpatient department with a diagnosis of a cardiovascular disease or a risk factor for cardiovascular disease. Patients who accepted to participate in the study were asked to answer a questionnaire; after that a blood sample was taken for lipid profile. An informed consent was signed by all the participants and the study has received approval from the national ethic committee. Results. We recruited 264 patients of which 119 were men and 145 were women with a sex ratio of 0.82. Mean age was 61.36 years. The frequency of lipid profiles abnormalities was as follows: low HDL cholesterol (44.3%), hypertriglyceridemia (18.9%), high LDL cholesterol (3.8%), and high total cholesterol 3.4%). Hypertriglyceridemia was strongly associated with type 2 diabetes mellitus. Conclusion. Low levels of HDL cholesterol and hypertriglyceridemia are more prevalent in our study population. More studies are needed to confirm this finding in our environment.
Conflict of interest statement
The authors declare that there are no competing interests regarding the publication of this paper.
Similar articles
-
Prevalence of dyslipidemia and its associated factors among university academic staff and students in Bangladesh.BMC Cardiovasc Disord. 2023 Jul 21;23(1):366. doi: 10.1186/s12872-023-03399-1. BMC Cardiovasc Disord. 2023. PMID: 37479968 Free PMC article.
-
The relationship between dyslipidemia and inflammation among adults in east coast China: A cross-sectional study.Front Immunol. 2022 Aug 11;13:937201. doi: 10.3389/fimmu.2022.937201. eCollection 2022. Front Immunol. 2022. PMID: 36032093 Free PMC article.
-
Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.Endocrine. 2008 Aug-Dec;34(1-3):36-51. doi: 10.1007/s12020-008-9100-z. Epub 2008 Nov 12. Endocrine. 2008. PMID: 19003544
-
Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.Am J Cardiovasc Drugs. 2005;5(6):379-87. doi: 10.2165/00129784-200505060-00005. Am J Cardiovasc Drugs. 2005. PMID: 16259526 Review.
-
Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.Pharmacotherapy. 1995 May-Jun;15(3):317-37. Pharmacotherapy. 1995. PMID: 7667166 Review.
Cited by
-
Vitamin D deficiency and cardiovascular risk in type 2 diabetes population.Open Life Sci. 2021 May 10;16(1):464-474. doi: 10.1515/biol-2021-0050. eCollection 2021. Open Life Sci. 2021. PMID: 34017921 Free PMC article.
-
Dyslipidemia and associated factors among adult cardiac patients: a hospital-based comparative cross-sectional study.Eur J Med Res. 2024 Apr 15;29(1):237. doi: 10.1186/s40001-024-01802-x. Eur J Med Res. 2024. PMID: 38622622 Free PMC article.
-
The relation between ApoB/ApoA-1 ratio and the severity of coronary artery disease in patients with acute coronary syndrome.Egypt Heart J. 2021 Mar 16;73(1):24. doi: 10.1186/s43044-021-00150-z. Egypt Heart J. 2021. PMID: 33725226 Free PMC article.
-
The status of zinc in type 2 diabetic patients and its association with glycemic control.J Family Community Med. 2020 Jan-Apr;27(1):29-36. doi: 10.4103/jfcm.JFCM_113_19. Epub 2020 Jan 13. J Family Community Med. 2020. PMID: 32030076 Free PMC article.
-
A Study to Assess and Correlate Serum Lipid Profile with Reaction Time in Healthy Individuals.Indian J Clin Biochem. 2020 Oct;35(4):482-487. doi: 10.1007/s12291-019-00850-z. Epub 2019 Sep 18. Indian J Clin Biochem. 2020. PMID: 33013019 Free PMC article.
References
-
- Fondation des Maladies du Coeur du Québec. Statistiques. 2010.
-
- AFSSAP (Agence Française de Sécurité Sanitaire des Produits de Santé) Prise en charge thérapeutique du patient dyslipidémique. Argumentaire. 2005:3–5. - PubMed
-
- OMS. Cadre Global Mondial de Suivi, Comprenant des Indicateurs, et Série de Cibles Mondiales Volontaires Pour la Lutte Contre les Maladies non Transmissibles. Geneva, Switzerland: OMS; 2012.
-
- OMS. Rapport sur la Situation Mondiale des Maladies non Transmissibles (Résumé d'Orientation) 2010. Geneva, Switzerland: OMS; 2011.
LinkOut - more resources
Full Text Sources
Other Literature Sources